Skip to content

Capital Research Global Investors: NVDA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Capital Research Global Investors on NVDA, newest first. How the timeline and the estimate are built.

Capital Research Global Investors held 202,740,420 NVDA shares at 2026-06-30 per its 13F-HR filed 2026-08-12.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 202,740,420 shares
    Change vs previous 13F +9,702,720 shares

    5.66% of the 13F portfolio, value $40,564,718,793.

    13F-HR 0001422848-26-000094 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 193,037,700 shares
    Change vs previous 13F +21,474,958 shares

    5.22% of the 13F portfolio, value $33,663,867,426.

    13F-HR 0001422848-26-000041 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 171,562,742 shares
    Change vs previous 13F +6,184,890 shares

    5.91% of the 13F portfolio, value $31,996,598,678.

    13F-HR 0001422848-26-000005 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 165,377,852 shares
    Change vs previous 13F +22,896,705 shares

    5.79% of the 13F portfolio, value $30,855,564,331.

    13F-HR 0001422848-25-000223 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 142,481,147 shares
    Change vs previous 13F +46,228,880 shares

    4.51% of the 13F portfolio, value $22,510,571,521.

    13F-HR 0001422848-25-000149 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 96,252,267 shares
    Change vs previous 13F +32,380,763 shares

    2.27% of the 13F portfolio, value $10,431,910,945.

    13F-HR 0000732812-25-000014 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 63,871,504 shares
    Change vs previous 13F +2,341,440 shares

    1.76% of the 13F portfolio, value $8,577,457,850.

    13F-HR 0001422848-25-000010 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 61,530,064 shares
    Change vs previous 13F not available

    1.55% of the 13F portfolio, value $7,472,209,068.

    13F-HR 0000017283-24-000030 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).